Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

HEH new 2014 masthead 021

September 1, 2022

View Archives Issues

  • The Darkest Hour: Little PPE, No Vaccine Led to Moral Injury

    A fascinating and disturbing study captures the emotions and attitudes of healthcare workers in 2020 when COVID-19 emerged. Personal protective equipment was in short supply, and the first COVID-19 vaccines would not be available until the end of the year. There was a general despairing feeling in this period that there was not “enough” of anything, including reliable information.

  • Moral Injury in HCWs at Level of Combat Vets

    Moral injury is a fairly well-established syndrome in combat soldiers, but researchers found healthcare workers suffered a comparable level of mental turmoil and ethical conflict during the first two years of the pandemic.

  • Dealing with Toxic Employees

    Everyone has met him or her — and would prefer not to meet them again. But there they are when you arrive for duty: The toxic co-worker.

  • Survey: 87% of Acute Care Sites Short of Nurses

    Healthcare delivery is at a critical tipping point due to a nursing shortage crisis that is projected to get worse, and no clear consensus on new labor models to meet the crisis, according to a survey and report by two companies involved in medical education and labor solutions. Even before the pandemic drove workers from the clinical bedside, experts projected 1 million more nurses would be needed by 2030.

  • Healthcare Workers Likely Will Be Offered New Vaccine

    Healthcare workers likely will be offered a new COVID-19 vaccine the FDA is pushing to roll out for this fall and winter. The FDA Vaccines and Related Biological Products Advisory Committee approved “the inclusion of a SARS-CoV-2 omicron component for COVID-19 booster vaccines in the United States.”